1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Washington, DC: American Psychiatric Publishing; 2010.
https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
. Accessed 3 Feb 2018.
2. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, reaffirmed; 2015.
https://www.guidelinecentral.com/summaries/practice-guideline-for-the-treatment-of-patients-with-major-depressive-disorder-third-edition/#section-420
. Accessed 17 July 2018.
3. Andreasen NC. Brave new brain: conquering mental illness in the era of the genome. New York: Oxford University Press; 2001.
4. Appelbaum PS, Gold A. Psychiatrists’ relationships with industry: the principal-agent problem. Harv Rev Psychiatry. 2010;18(5):255–65.
https://doi.org/10.3109/10673229.2010.507038
.
5. Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. Eur Neuropsychopharmacol. 2016;26(3):411–9.
https://doi.org/10.1016/j.euroneuro.2016.02.001
.